Use of a medicament containing an effector of the glutathione metabolism together with α-lipoic acid in kidney replacement therapy

US7531567B2 · kind B2 · utility

Assignee

• Serumwek Bernburg AG · DE

Inventors

• Michael Täger · Heinrichsberg, DE
• Siegfried Ansorge · Hohenwarthe, DE
• Gerhard Fries · Gommern, DE
• Dieter Koegst · Osterweddingen, DE

Key dates

• Filing date: May 24, 2002
• Grant date: May 12, 2009
• Expiry date: May 24, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of the combination of n-lipoic acid and effectors of the glutathione metabolism for the treatment of disturbances of the cellular thiol status and accompanying disorders in kidney replacement therapy.